Primary Graft Dysfunction in Lung Transplantation

ABSTRACT

Following the initial successful lung transplants reported by the Toronto Lung Transplant Group in 1986, lung transplantation has evolved into an effective treatment of isolated pulmonary failure and has been performed in more than 20,000 recipients. Increased experience, adjustments, and additions to the surgical technique and improved perioperative care have combined to decrease morbidity and improve survival in lung transplant recipients. An area in which improvements have been made but that continues to cause major morbidity, mortality, and impact on long-term allograft function is primary allograft dysfunction, which occurs in 11 to 60% transplant patients, depending on the diagnostic criteria applied. The basis of this potentially devastating complication is likely ischemia reperfusion injury of the donor allograft with activation of recipient innate immunity. This article discusses mechanisms of primary graft dysfunction in light of recent International Society for Heart and Lung Transplantation consensus definitions, and considers successful strategies for prevention and treatment of primary graft dysfunction.

KEYWORDS

Lung - allograft - dysfunction - transplant - complication

REFERENCES

• 1 Christie J D, Kotloff R M, Pochettino A et al.. Clinical risk factors for primary graft failure following lung transplantation.  Chest. 2003;  124 1232-1241
• 2 King R C, Binns O A, Rodriguez F et al.. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation.  Ann Thorac Surg. 2000;  69 1681-1685
• 3 Christie J D, Bavaria J E, Palevsky H I et al.. Primary graft failure following lung transplantation.  Chest. 1998;  114 51-60
• 4 Khan S U, Salloum J, O'Donovan P B et al.. Acute pulmonary edema after lung transplantation: the pulmonary reimplantation response.  Chest. 1999;  116 187-194
• 5 Thabut G, Vinatier I, Stern J B et al.. Primary graft failure following lung transplantation: predictive factors of mortality.  Chest. 2002;  121 1876-1882
• 6 Hartwig M G, Davis R D. Surgical considerations in lung transplantation: transplant operation and early postoperative management.  Respir Care Clin. 2004;  15 473-504
• 7 Fiser S M, Tribble C G, Long S M et al.. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome.  Ann Thorac Surg. 2002;  73 1041-1047
• 8 Fisher A J, Wardle J, Dark J H, Corris P A. Nonimmune acute graft injury after lung transplantation and the risk of subsequent bronchiolitis obliterans syndrome (BOS).  J Heart Lung Transplant. 2002;  21 1206-1212
• 9 Khan S U, Salloum J, O'Donovan P B et al.. Acute pulmonary edema after lung transplantation: the pulmonary reimplantation response.  Chest. 1999;  116 187-194
• 10 Chatila W M, Furukawa S, Gaughan J P, Criner G J. Respiratory failure after lung transplantation.  Chest. 2003;  123 165-173
• 11 Whitson B A, Nath D S, Johnson A C et al.. Risk factors for primary graft dysfunction after lung transplantation.  J Thorac Cardiovasc Surg. 2006;  131 73-83
• 12 Trulock E P, Edwards L B, Taylor D O et al.. The registry of the International Society for Heart and Lung Transplantation: twentieth official adult lung and heart-lung transplant report.  J Heart Lung Transplant. 2003;  22 625-635
• 13 Meyers B F, de la Morena M, Sweet S C et al.. Primary graft dysfunction and other selected complications of lung transplantation: a single-center experience of 983 patients.  J Thorac Cardiovasc Surg. 2005;  129 1421-1429
• 14 Kundu S, Herman S J, Winton T L. Reperfusion edema after lung transplantation: radiographic manifestations.  Radiology. 1998;  206 75-80
• 15 Fehrenbach H, Schepelmann D, Albes J M et al.. Pulmonary ischemia/reperfusion injury: a quantitative study of structure and function in isolated heart-lungs of the rat.  Anat Rec. 1999;  255 84-89
• 16 Fiser S M, Kron I L, Long S M et al.. Influence of graft ischemic time on outcomes following lung transplantation.  J Heart Lung Transplant. 2001;  20 1291-1296
• 17 King R C, Binns O A, Rodriguez F et al.. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation.  Ann Thorac Surg. 2000;  69 1681-1685
• 18 Egan T M, Detterbeck F C, Mill M R et al.. Long-term results of lung transplantation for cystic fibrosis.  Eur J Cardiothorac Surg. 2002;  22 602-609
• 19 Schnickel G T, Ross D J, Beygui R et al.. Modified reperfusion in clinical lung transplantation: the result of 100 consecutive cases.  J Thorac Cardiovasc Surg. 2006;  131 218-223
• 20 Gammie J S, Stukus D R, Pham S M et al.. Effect of ischemic time on survival in clinical lung transplantation.  Ann Thorac Surg. 1999;  68 2015-2020
• 21 Ueno T, Snell G I, William T J et al.. Impact of graft ischemic time on outcomes after bilateral sequential single-lung transplantation.  Ann Thorac Surg. 1999;  67 1577-1582
• 22 Shumway S J, Hertz M I, Petty M G, Bolman III R M. Liberalization of donor criteria in lung and heart-lung transplantation.  Ann Thorac Surg. 1994;  57 92-95
• 23 Sundaresan S, Semenkovich J, Ochoa L et al.. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs.  J Thorac Cardiovasc Surg. 1995;  109 1075-1079
• 24 Sundaresan S, Trachiotis G D, Aoe M et al.. Aggressive management of lung donors classified as unacceptable: excellent recipient survival one year after transplantation.  Ann Thorac Surg. 1993;  56 1409-1413
• 25 Straznicka M, Follette D M, Eisner M D et al.. Aggressive management of lung donors classified as unacceptable: excellent recipient survival one year after transplantation.  J Thorac Cardiovasc Surg. 2002;  124 250-258
• 26 Pierre A F, Sekine Y, Hutcheon M A, Waddell T K, Keshavjee S H. Marginal donor lungs: a reassessment.  J Thorac Cardiovasc Surg. 2002;  123 421-427
• 27 Arcasoy S M, Fisher A, Hachem R R, Scavuzzo M, Ware L B. Report of the ISHLT working group on primary lung graft dysfunction, V: Predictors and outcomes.  J Heart Lung Transplant. 2005;  24 1483-1488
• 28 Waddell T K, Gorczynski R M, DeCampos K N, Patterson G A, Slutsky A S. Major histocompatibility complex expression and lung ischemia-reperfusion in rats.  Ann Thorac Surg. 1996;  62 866-872
• 29 de Perrot M, Sekine Y, Fisher S et al.. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation.  Am J Respir Crit Care Med. 2002;  165 211-215
• 30 Fisher A J, Donnelly S C, Hirani N et al.. Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation.  Am J Respir Crit Care Med. 2001;  163 259-265
• 31 DiGiovine B, Lynch III J P, Martinez F J et al.. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8.  J Immunol. 1996;  157 4194-4202
• 32 Meyers B F, Sundt III T M, Henry S et al.. Selective use of extracorporeal membrane oxygenation is warranted after lung transplantation.  J Thorac Cardiovasc Surg. 2000;  120 20-26
• 33 Hartwig M G, Appel J Z, Cantu E et al.. Improved results treating lung allograft failure with venovenous extracorporal membrane oxygenation.  Ann Thorac Surg. 2005;  80 1872-1880
• 34 Date H, Triantafillou A N, Trulock E P, Pohl M S, Cooper J D, Patterson G A. Inhaled nitric oxide reduces human lung allograft dysfunction.  J Thorac Cardiovasc Surg. 1996;  111 913-919
• 35 Macdonald P, Mundy J, Rogers P et al.. Successful treatment of life-threatening acute reperfusion injury after lung transplantation with inhaled nitric oxide.  J Thorac Cardiovasc Surg. 1995;  110 861-863
• 36 Adatia I, Lillehia C, Arnold J H et al.. Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation.  Ann Thorac Surg. 1994;  57 1311-1318
• 37 Hermle G, Schutte H, Walmrath D, Geiger K, Seeger W, Grimminger F. Ventilation - perfusion mismatch after lung ischemia-reperfusion: protective effect of nitric oxide.  Am J Respir Crit Care Med. 1999;  160 1179-1187
• 38 Murakami S, Bacha E A, Mazmanian G M et al.. Effects of various timing and concentrations of inhaled nitric oxide in lung ischemia-reperfusion. The Paris-Sud University Lung Transplantation Group.  Am J Respir Crit Care Med. 1997;  156(2 Pt 1) 454-458
• 39 Bhabra M S, Hopkinson D N, Shaw T E, Hooper T L. Low-dose nitric oxide inhalation during initial reperfusion enhances rat lung graft function.  Ann Thorac Surg. 1997;  63 339-344
• 40 Bhabra M S, Hopkinson D N, Shaw T E, Hooper T L. Attenuation of lung graft reperfusion injury by a nitric oxide donor.  J Thorac Cardiovasc Surg. 1997;  113 327-333
• 41 Mayer E, Puskas J D, Cardoso P FG, Shi S, Slutsky A S, Patterson G A. Reliable eighteen-hour lung preservation at 4 degree and 10 degree Celsius by pulmonary artery flush after high-dose prostaglandin E1 administration.  J Thorac Cardiovasc Surg. 1992;  103 1136-1142
• 42 Naka Y, Roy D K, Liao H et al.. cAMP-mediated vascular protection in an orthotopic rat lung transplant model. Insights into the mechanism of action of prostaglandin E1 to improve lung preservation.  Circ Res. 1996;  79 773-783
• 43 Chiang C H, Wu K, Yu C P, Yan H C, Perng W C, Wu C P. Hypothermia and prostaglandin E1 produce synergistic attenuation of ischemia-reperfusion lung injury.  Am J Respir Crit Care Med. 1999;  160 1319-1323
• 44 Ueno T, Yokomise H, Oka T et al.. The effect of PGE1 and temperature on lung function following preservation.  Transplantation. 1991;  52 626-630
• 45 de Perrot M, Liu M, Jin R, Xiao-Hui B, Waddell T K, JKeshavjee S. Prostaglandin protects lung transplants from ischemia-reperfusion injury: a shift from pro- to antiinflammatory cytokines.  Transplant. 2001;  72 1505-1512
• 46 Korom S, Hillinger S, Cardell M et al.. Sildenafil extends survival and graft function in a large animal lung transplant model.  Eur J Cardiothorac Surg. 2006;  29 288-293
• 47 Kron I L, Tribble C G, Kern J A et al.. Successful transplantation of marginally acceptable thoracic organs.  Ann Surg. 1993;  217 518-522
• 48 Bhabra M S, Hopkinson D N, Shaw T E, Onwu N, Hooper T L. Controlled reperfusion protects lung grafts during a transient early increase in permeability.  Ann Thorac Surg. 1998;  65 187-192
• 49 Ng C SH, Wan S, Arifi A A, Yim A PC. Inflammatory response to pulmonary ischemia-reperfusion injury.  Surg Today. 2006;  36 205-214
• 50 Thabut G, Brugiere O, Leseche G et al.. Preventive effect of inhaled nitric oxide and pentoxifylline on ischemia/reperfusion injury after lung transplantation.  Transplantation. 2001;  71 1295-1300
• 51 de Perrot M, Bonser R S, Dark J et al.. Report of the ISHLT working group on primary lung graft dysfunction, III: Donor-related risk factors and markers.  J Heart Lung Transplant. 2005;  24 1460-1467
• 52 Colombat M, Castier Y, Leseche G et al.. Early expression of adhesion molecules after lung transplantation: evidence for a role of aggregated P-selectin positive platelets in human primary graft failure.  J Heart Lung Transplant. 2004;  23 1087-1092